PDX
CTG-1269
Tumor type
NSCLC
Treatment history
Pretreated
Availability
- Model status
- Established
- CTG3D/DTG organoid formation
- Yes
- CTG3D/DTG proliferation status
- Yes
Details
- Tumor type
- NSCLC
- Tumor subtype
- N/A
- Tumor status
- Metastatic
- Disease stage
- IV
- Harvest site
- Crizotinib Resistant Laboratory Clone
- Histology
- Adenocarcinoma
- Tumor grade
- Poorly Differentiated
- Diagnosis
- Recurrent
- Treatment history
- Pretreated
- Smoking history
- Non-Smoker
- Gender
- Female
- Ethnicity
- Caucasian
- Age
- 34
Request more information
Let's build the right study, together.
Backed by deep expertise in these models, our team will work with you to design the study around your target, line of therapy, and endpoint.